David Meltzer of “Office Hours” interviews Jonathan C. Javitt, M.D., M.P.H./Chief Scientist, Director, and Founder, NRx Pharmaceuticals to discuss the anti-depressant effect of Ketamine.
ketamine
Jan. 18, 2024
David Meltzer of “Office Hours” interviews Jonathan C. Javitt, M.D., M.P.H./Chief Scientist, Director, and Founder, NRx Pharmaceuticals to discuss the anti-depressant effect of Ketamine
Jan. 10, 2024
Jonathan Javitt, MD, MPH, Founder, Chairman, and Chief Scientist of NRx Pharmaceuticals, gives the keynote address “Ketamine for Suicidal Depression: The Benefits are Clear, But So are the Risks,” at the Sachs Neuroscience Innovation Forum in San Francisco, CA on January 7, 2024
Jonathan Javitt, MD, MPH, Founder, Chairman, and Chief Scientist of NRx Pharmaceuticals, gives the keynote address “Ketamine for Suicidal Depression: The Benefits are Clear, But So are the Risks,” at the Sachs Neuroscience Innovation Forum in San Francisco, CA on January 7, 2024.
Dec. 27, 2023
The Big Biz Show interviews Jonathan C. Javitt, M.D., M.P.H., Chairmain & Chief Scientist, NRx Pharmaceuticals to discuss the anti-depressant effect of Ketamine
The Big Biz Show interviews Jonathan C. Javitt, M.D., M.P.H., Chairman and Chief Scientist, NRx Pharmaceuticals, discussing the anti-depressant effect of Ketamine.
- 1
- 2